Stock listing
NASDAQ:WOK WORK Medical Technology Group LTD Stock
Home listing (NASDAQ) of WORK Medical Technology Group LTD
Follow WORK Medical Technology Group LTD into a list and get an email when it puts out news.
Share price · NASDAQ:WOK
$1.10 USD -0.06 (-5.5%)
Close on Nov 20, 2026
- Day range
- $1.05 – $1.17 USDNov 20, 2026
- Volume
- 18,351 sharesNov 20, 2026
- Market cap
- $4.84M USDAt the close on Nov 20, 2026 · price × 4.42M shares outstanding
- 52-week range
- $0.91 – $83,600.00 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $128,523 USDMedian day 45,395 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:WOK · Home | $1.096 USD | -0.064 (-5.5%) | 18,351 | $1.14 | $1.171 | $1.05 | $1.16 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:WOK · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.096 | -0.064 | -5.5% | $1.14 | $1.171 | $1.05 | 18,351 | |
| $1.16 | -0.032 | -2.7% | $1.135 | $1.21 | $1.135 | 10,388 | |
| $1.192 | -0.038 | -3.1% | $1.22 | $1.232 | $1.10 | 34,758 | |
| $1.23 | +0.03 | +2.5% | $1.17 | $1.29 | $1.17 | 30,993 | |
| $1.20 | -0.05 | -4.0% | $1.24 | $1.30 | $1.20 | 32,387 | |
| $1.25 | -0.12 | -8.8% | $1.33 | $1.354 | $1.201 | 34,649 | |
| $1.37 | +0.21 | +18.1% | $1.18 | $1.48 | $1.17 | 169,636 | |
| $1.16 | -0.09 | -7.2% | $1.26 | $1.26 | $1.13 | 122,061 | |
| $1.25 | +0.305 | +32.2% | $0.96 | $1.50 | $0.91 | 1,418,816 | |
| $0.945 | +0.025 | +2.8% | $0.961 | $0.983 | $0.93 | 28,666 | |
| $0.92 | -0.12 | -11.5% | $1.04 | $1.04 | $0.92 | 76,558 | |
| $1.04 | -0.02 | -1.9% | $1.05 | $1.13 | $1.04 | 25,500 | |
| $1.06 | +0.06 | +6.0% | $1.031 | $1.07 | $1.03 | 13,690 | |
| $1.00 | 0.00 | 0.0% | $1.04 | $1.05 | $1.00 | 31,962 | |
| $1.00 | -0.10 | -9.1% | $1.07 | $1.10 | $1.00 | 61,180 | |
| $1.10 | -0.05 | -4.3% | $1.16 | $1.16 | $1.10 | 12,647 | |
| $1.15 | -0.02 | -1.7% | $1.15 | $1.16 | $1.14 | 17,675 | |
| $1.17 | +0.04 | +3.5% | $1.164 | $1.19 | $1.13 | 22,594 | |
| $1.13 | +0.02 | +1.8% | $1.11 | $1.14 | $1.11 | 20,416 | |
| $1.11 | -0.02 | -1.8% | $1.133 | $1.133 | $1.09 | 29,437 | |
| $1.13 | -0.05 | -4.2% | $1.18 | $1.181 | $1.10 | 48,172 | |
| $1.18 | +0.03 | +2.6% | $1.15 | $1.18 | $1.14 | 35,575 | |
| $1.15 | -0.05 | -4.2% | $1.17 | $1.27 | $1.15 | 52,395 | |
| $1.20 | +0.11 | +10.1% | $1.14 | $1.23 | $1.12 | 71,569 | |
| $1.09 | -0.25 | -18.7% | $1.30 | $1.36 | $1.01 | 107,631 | |
| $1.34 | -0.005 | -0.4% | $1.30 | $1.34 | $1.25 | 40,886 | |
| $1.345 | -0.045 | -3.2% | $1.34 | $1.38 | $1.29 | 46,362 | |
| $1.39 | -0.05 | -3.5% | $1.45 | $1.45 | $1.38 | 36,708 | |
| $1.44 | -0.09 | -5.9% | $1.48 | $1.53 | $1.44 | 31,889 | |
| $1.53 | +0.01 | +0.7% | $1.52 | $1.55 | $1.50 | 28,273 | |
| $1.52 | -0.03 | -1.9% | $1.53 | $1.55 | $1.51 | 27,525 | |
| $1.55 | +0.05 | +3.3% | $1.49 | $1.598 | $1.49 | 40,796 | |
| $1.50 | +0.035 | +2.4% | $1.48 | $1.537 | $1.47 | 46,738 | |
| $1.465 | -0.245 | -14.3% | $1.70 | $1.72 | $1.40 | 149,548 | |
| $1.71 | -0.05 | -2.8% | $1.785 | $1.792 | $1.66 | 61,678 | |
| $1.76 | -0.01 | -0.6% | $1.78 | $1.80 | $1.76 | 33,548 | |
| $1.77 | -0.04 | -2.2% | $1.80 | $1.834 | $1.75 | 40,588 | |
| $1.81 | -0.04 | -2.2% | $1.86 | $1.86 | $1.80 | 22,855 | |
| $1.85 | -0.06 | -3.1% | $1.88 | $1.916 | $1.85 | 26,598 | |
| $1.91 | +0.07 | +3.8% | $1.87 | $1.98 | $1.85 | 112,125 | |
| $1.84 | -0.02 | -1.1% | $1.86 | $1.90 | $1.82 | 46,087 | |
| $1.86 | -0.04 | -2.1% | $1.897 | $1.897 | $1.85 | 23,899 | |
| $1.90 | +0.01 | +0.5% | $1.875 | $1.929 | $1.86 | 24,178 | |
| $1.89 | -0.02 | -1.0% | $1.88 | $1.95 | $1.88 | 36,556 | |
| $1.91 | +0.01 | +0.5% | $1.89 | $1.95 | $1.85 | 52,287 | |
| $1.90 | +0.08 | +4.4% | $1.815 | $1.97 | $1.815 | 54,767 | |
| $1.82 | 0.00 | 0.0% | $1.83 | $1.86 | $1.80 | 52,274 | |
| $1.82 | -0.10 | -5.2% | $1.90 | $1.90 | $1.81 | 45,395 | |
| $1.92 | +0.04 | +2.1% | $1.86 | $1.92 | $1.86 | 40,114 | |
| $1.88 | -0.05 | -2.6% | $1.95 | $1.96 | $1.858 | 82,759 | |
| $1.93 | -0.09 | -4.5% | $1.97 | $2.08 | $1.93 | 49,497 | |
| $2.02 | -0.03 | -1.5% | $2.08 | $2.08 | $2.00 | 36,800 | |
| $2.05 | -0.05 | -2.4% | $2.09 | $2.15 | $2.03 | 54,090 | |
| $2.10 | +0.03 | +1.4% | $2.04 | $2.13 | $2.01 | 35,105 | |
| $2.07 | -0.08 | -3.7% | $2.16 | $2.17 | $2.06 | 64,118 | |
| $2.15 | -0.07 | -3.2% | $2.10 | $2.25 | $2.09 | 85,836 | |
| $2.22 | -0.02 | -0.9% | $2.22 | $2.29 | $2.19 | 55,763 | |
| $2.24 | -0.09 | -3.9% | $2.33 | $2.33 | $2.21 | 57,942 | |
| $2.33 | -0.02 | -0.9% | $2.33 | $2.36 | $2.28 | 57,346 | |
| $2.35 | +0.10 | +4.4% | $2.31 | $2.40 | $2.21 | 139,835 | |
| $2.25 | -0.03 | -1.3% | $2.26 | $2.26 | $2.20 | 59,598 | |
| $2.28 | +0.06 | +2.7% | $2.20 | $2.28 | $2.17 | 94,511 | |
| $2.22 | -0.06 | -2.6% | $2.26 | $2.26 | $2.11 | 87,603 | |
| $2.28 | -0.02 | -0.9% | $2.30 | $2.32 | $2.19 | 247,424 | |
| $2.30 | +0.15 | +7.0% | $2.14 | $2.38 | $2.08 | 329,389 |
Splits
3 splits since 2025 · NASDAQ:WOK · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-100 | Consolidation | |
| 1-for-100 | Consolidation | |
| 1-for-100 | Consolidation |
- Ticker
- NASDAQ:WOK
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Jun 16, 2026
WORK Medical Announces 1-for-100 Reverse Stock Split Effective June 18, 2026
Latest news
WORK Medical Announces 1-for-100 Reverse Stock Split Effective June 18, 2026
Jun 16, 2026
Closed $5.07 (-40.8%) on Jun 16, 2026
WORK Medical Technology Group Participated in 2026 CBA-China Annual Conference
Jun 5, 2026
Closed $8.70 (-15.7%) on Jun 5, 2026
WORK Medical Technology Group Establishes U.S. Subsidiary to Advance Global Expansion and Reinforce Long-Term Growth Strategy
Jun 3, 2026
Closed $10.71 (+3.0%) on Jun 3, 2026
WORK Medical Collaborates with Novabioplus to Unlock Biological Data Value with AI, Advancing the “BioToken” Assetization Model
May 11, 2026
Closed $392.00 (+206.3%) on May 11, 2026
WORK Medical Deepens Web3.0 Strategic Layout: Co-authors Asset Tokenization Whitepaper
May 1, 2026
Closed $129.00 (+6.6%) on May 1, 2026
WORK Medical Grants East China Exclusive Distribution Rights for AI-Automated Blood Cell Morphology Analyzer, Sets RMB10 Million Sales Target for 2026
Dec 29, 2025
Closed $341.00 (+24.0%) on Dec 29, 2025
WORK Medical Technology Group LTD Subsidiary Obtains Manufacturing Approval for Its AI-Automated Blood Cell Morphology Analyzer
Dec 29, 2025
Closed $341.00 (+24.0%) on Dec 29, 2025
WORK Medical Technology Group LTD Announces 1-for-100 Reverse Stock Split Effective December 29, 2025
Dec 24, 2025
Closed $328.00 (-32.9%) on Dec 24, 2025
WORK Medical Technology Group LTD on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 8 in the last 12 months · 26 in all · newest Jun 16, 2026 · oldest 2024
- Decks
- 3 decks · latest Aug 9, 2024
Where WORK Medical Technology Group LTD is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:WOK · Home listing · This page | NASDAQ | United States | USD |
| BOATS:WOK | BOATS | United States | USD |
Valuation
EV/sales 0.8× against a median of 0.4×: 6th lowest of 7 Medical devices & supplies companies shown. Statements: Year to Sep 30, 2025 · balance Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- $8.21M USD
- P/E
- Loss
- EV/sales
- 0.8×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 0.2×
- Gross margin
- 23.8%
- Operating margin
- −25.3%
- Net margin
- −10.9%
- Debt to equity
- 0.2×
- Beta vs S&P 500
- 2.76
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| WORK Medical Technology Group LTD · NASDAQ:WOK | US$4.84M | US$8.21M | n/a | 0.8× | n/a | 0.2× | −10.9% | 0.2× | 2.76 |
| NeuroOne Medical Technologies Corporation · NASDAQ:NMTC | US$5.94M | US$3.89M | n/a | 0.4× | n/a | 1.6× | −78.6% | 0.0× | 1.07 |
| Neola Medical AB · OMXSTO:NEOLA | US$5.46M | US$5.07M | n/a | n/a | n/a | 0.6× | n/a | 0.0× | n/a |
| ENDRA Life Sciences Inc. · NASDAQ:NDRA | US$5.36M | US$3.85M | n/a | n/a | n/a | 1.0× | n/a | 0.0× | 1.07 |
| MEKICS Co., Ltd. · KRX:058110 | US$5.23M | US$2.04M | 6.6× | 0.2× | 1.3× | 0.2× | 7.7% | 0.1× | n/a |
| PT Hetzer Medical Indonesia Tbk · IDX:MEDS | US$5.16M | US$5.45M | n/a | n/a | n/a | 1.8× | n/a | 0.1× | n/a |
| Regentis Biomaterials Ltd. · AMEX:RGNT | US$5.05M | −US$3.90M | n/a | n/a | n/a | 0.7× | n/a | 0.0× | 2.00 |
| SeaStar Medical Holding Corporation · NASDAQ:ICU | US$4.97M | US$981,429 | n/a | 0.5× | n/a | 10.6× | −678.2% | 0.0× | 1.44 |
| Kelyniam Global, Inc. · OTC:KLYG | US$4.56M | US$4.84M | n/a | 1.4× | 31.9× | 6.6× | −6.0% | 0.6× | 1.15 |
| Meihua International Medical Technologies Co., Ltd. · OTC:MHUAF | US$4.53M | −US$1.63M | 0.7× | −0.0× | −0.2× | 0.0× | 11.0% | 0.1× | 0.62 |
| Aurora Spine Corp. · TSXV:ASG | US$4.36M | US$6.91M | n/a | 0.4× | 45.6× | 1.5× | −7.0% | 1.0× | -0.13 |
| Median of the others | US$5.11M | US$3.87M | 3.7× | 0.4× | 16.6× | 1.3× | −6.5% | 0.0× | 1.07 |
Team and board
Officers
| Officer | Role |
|---|---|
| Ningfang Liang | Chief Executive Officer, Director, and Chairman of the Board of Directors |
| Baiming Yu | Chief Financial Officer |
| Shuang Wu | Chief Operating Officer and Director Appointee |
| Tina Xiao | Ascent Investor Relations LLC |
Board
| Director | Role |
|---|---|
| Ningfang Liang | Chief Executive Officer, Director, and Chairman of the Board of Directors |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q3 2025 | Aug 25, 2025 | +1.0% |
| Q1 2025 | Feb 14, 2025 | −12.4% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| IPO Roadshow (August 2024) | IPO roadshow | 24 slides | Aug 9, 2024 |
| IPO Roadshow (May 2024) | IPO roadshow | 24 slides | May 21, 2024 |
| IPO Roadshow (March 2024) | IPO roadshow | 23 slides | Mar 25, 2024 |
Financings
| Raise | Date |
|---|---|
| Registered direct offering of class A ordinary shares (or pre-funded warrants) Closed: US$2.9M raised · US$0.075 a share · Univest Securities, LLC Dealers: Univest Securities, LLC (lead) | Sep 26, 2025 |
| Public offering of ordinary units Closed: US$5M raised · US$0.5 a unit · Warrants at US$1 for 12 months · Univest Securities, LLC Dealers: Univest Securities, LLC (lead) Use of proceeds: Upgrading production equipment, R&D at PRC subsidiaries, hiring for internal control and compliance, working capital and general corporate purposes | May 22, 2025 |
Open Financings · Read by 6ix AI from the company's releases
IPO
Priced at US$4.00 a share on Aug 22, 2024.
- Price
- US$4.00 a share
- Shares offered
- 2,000,000 ordinary shares
- Offering size
- US$8 million
- Listing
- WOK on Nasdaq
- Shares delivered
- On or about Aug 26, 2024
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Jun 23, 2022 |
| Filed publicly | Apr 27, 2023 |
| Amended 14 times | Newest Aug 2, 2024 |
| Shares registered with an exchange | Aug 20, 2024 |
| Declared effective by the SEC | Aug 22, 2024 |
| Final prospectus, with the price | Aug 26, 2024 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Aug 26, 2024 |
| EFFECT · Notice that a registration is effective | Aug 22, 2024 |
| CERT · Exchange's certificate of listing | Aug 22, 2024 |
| 8-A12B · Registration of shares for listing on an exchange | Aug 20, 2024 |
| CORRESP · Letter to the SEC | Aug 20, 2024 |
| CORRESP · Letter to the SEC | Aug 20, 2024 |
| FWP · Free writing prospectus | Aug 9, 2024 |
| CORRESP · Letter to the SEC | Aug 2, 2024 |
| F-1/A · Registration statement, amended | Aug 2, 2024 |
| CORRESP · Letter to the SEC | Jul 17, 2024 |
All 55 filings
Open IPO · From the cover of the final prospectus (424B4) filed Aug 26, 2024
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 9.85M | 11.5M | 13.6M | 19.7M | 45.9M | 52.5M |
| Cost of revenue | 7.50M | 8.64M | 9.42M | 15.3M | 37.2M | 41.7M |
| Gross profit | 2.34M | 2.87M | 4.14M | 4.42M | 8.64M | 10.8M |
| Research and development | 435.3K | 302.5K | 301.6K | 183.9K | 186.4K | 797.4K |
| Selling, general and administrative | 2.33M | 4.56M | 1.86M | 2.56M | 2.89M | 2.84M |
| Operating income | -2.50M | -3.70M | 486.5K | 1.82M | 7.67M | 5.99M |
| Depreciation and amortization | 923.1K | 1.41M | 1.60M | 3.26M | 4.19M | 3.16M |
| EBITDA | -1.57M | -2.29M | 2.09M | 5.08M | 11.9M | 9.15M |
| Interest expense | 503.5K | 557.6K | 392.7K | 353.0K | 329.5K | 260.0K |
| Income before tax | -1.08M | -3.67M | 110.4K | 1.11M | 7.34M | 1.33M |
| Income tax | 119.1K | -125.3K | 47.0K | 169.4K | 1.08M | 108.9K |
| Net income | -1.07M | -3.49M | 112.0K | 865.2K | 5.96M | 1.16M |
| Earnings per share, basic | -0.04 | -0.27 | 0.01 | 0.07 | 47.67 | 1.16 |
| Earnings per share, diluted | -0.04 | -0.27 | 0.01 | 0.07 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Cash and equivalents | 4.09M | 6.56M | 1.60M | 731.2K | 508.7K | 200.4K |
| Receivables | 615.8K | 1.65M | 3.33M | 6.15M | 6.57M | 622.9K |
| Inventory | 2.46M | 3.18M | 4.62M | 4.36M | 6.29M | 12.9M |
| Current assets | 20.5M | 20.8M | 22.2M | 16.6M | 18.1M | 40.4M |
| Property, plant and equipment | 10.6M | 11.4M | 6.63M | |||
| Total assets | 33.2M | 36.3M | 30.0M | 25.5M | 30.7M | 56.2M |
| Accounts payable | 1.72M | 1.50M | 3.96M | 3.20M | 9.04M | 11.4M |
| Current liabilities | 12.0M | 20.2M | 18.9M | 14.3M | 18.9M | 49.6M |
| Long-term debt | 589.1K | |||||
| Total debt | 6.45M | 13.5M | 9.10M | 6.30M | 6.60M | 4.05M |
| Total liabilities | 12.0M | 20.2M | 19.0M | 14.4M | 19.3M | 50.3M |
| Shareholders' equity | 18.3M | 13.2M | 9.88M | 11.2M | 10.0M | 4.90M |
| Shares outstanding | 289.8K | 14.6M | 12.5M | 14.6M | 125.0K | 1.00M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Cash from operations | 6.24M | -2.23M | 2.21M | -2.26M | -7.18M | 27.2M |
| Capital spending | -1.33M | -9.23M | -455.4K | -2.01M | -60.0K | -17.5M |
| Free cash flow | 4.91M | -11.5M | 1.75M | -4.27M | -7.24M | 9.65M |
| Cash from investing | -7.61M | -9.06M | -583.3K | -1.35M | -60.0K | -16.8M |
| Cash from financing | -898.2K | 15.7M | -728.7K | 3.57M | 7.99M | -10.3M |
| Change in cash | -2.47M | 4.92M | 863.9K | -99.7K | 672.7K | -53.6K |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 6-K · Report of a foreign issuer | Nov 4, 2026 | Current report | SEC |
| 6-K · Report of a foreign issuer | Aug 24, 2026 | Current report | SEC |
| 6-K · Report of a foreign issuer | Aug 14, 2026 | Current report | SEC |
| 6-K · Report of a foreign issuer | Aug 14, 2026 | Current report | SEC |
| 4 · Change in ownership | Jun 23, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 17, 2026 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Jun 16, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Jun 16, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 12, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jun 12, 2026 | Insider trade | SEC |
All 144 filings
Cap table
Built by 6ix from WORK Medical Technology Group LTD’s releases · as of Sep 26, 2025
- Common shares
- 4,416,569
- Fully diluted
- 4,416,569
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 4,416,569 |
Warrants and options
| Lot |
|---|
| Warrants · US$1.00 · expire about May 2026 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 4,416,569 |
| Jun 16, 2026 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Robert Brian Johnson Other companies: EZGO Technologies Ltd. (Director · Since at least Mar 18, 2026) | Director · Since at least Mar 18, 2026 |
| Zhenguo Wu Other companies: EZGO Technologies Ltd. (Director · Since at least Mar 18, 2026) | Director · Since at least Mar 18, 2026 |
| Baiming Yu | COO and Director, Director · Since at least Mar 18, 2026 |
| Edric Guo | Chief Executive Officer · Sep 26, 2025 – Nov 4, 2026 · Past |
| Ningfang Liang | Chief Financial Officer · Since at least Mar 18, 2026 |
| Qisheng Lin | Director · Since at least Mar 18, 2026 |
| Shuang Wu | Chief Operating Officer and Director Appointee · Since at least Dec 29, 2025 |
| Tina Xiao | Ascent Investor Relations LLC · Since at least Jun 16, 2026 |
Log in to ask 6ix AI your own questions about WORK Medical Technology Group LTD.